🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether QAW039 is safe and has be...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-06
Trial ID
NCT01785602
This study will evaluate and follow patients with various allergic, hyperse...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
1996-08-26
Trial ID
NCT00557895
The trial is an exploratory, single-centre, uncontrolled, open-label, inter...
Status
Withdrawn
Location
Investigational site
Start Date
2019-01-14
Trial ID
NCT03710044
Treatments Being Tested
This study is an randomized double-blind placebo-controlled study to evalua...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin
Start Date
2013-11
Trial ID
NCT02004119
This study is not being conducted in the United States of America (USA). A...
Status
Completed
Location
This study is not being conducted in the United States
Start Date
2005-08
Trial ID
NCT00130364
Treatments Being Tested
Activation of mast cells in the immune system is known to cause allergic re...
Status
Completed
Location
Hong Kong Sanatorium & Hospital
Start Date
2018-02-01
Trial ID
NCT03406325
This is a Randomized, Double-blind, Vehicle-Controlled, Seamless and Adapti...
Status
Unknown
Location
Anhui Provincial Hospital
Start Date
2020-12-30
Trial ID
NCT04717310
Treatments Being Tested
This is a Phase 1, randomized, 2 way crossover, open label study of the eff...
Status
Completed
Location
Pfizer Clinical Research Unit
Start Date
2019-01-10
Trial ID
NCT03796182
Treatments Being Tested
Psoriasis is a common inflammatory disease of the skin and joints with a pr...
Status
Completed
Location
Dep. of Dermatology
Start Date
2011-03
Trial ID
NCT01356758
Treatments Being Tested
Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-S...
Status
Active Not Recruiting
Location
Galderma Investigational Site 8749
Start Date
2019-12-30
Trial ID
NCT03989206
Treatments Being Tested